ALLYSON QUINN: Open Payments
NPI 1417733940 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 46 payments from 17 companies in 2025. Trend: 2023 $40 · 2024 $793 · 2025 $1,305
Food & beverage: $1,305
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $243 |
| Novo Nordisk Inc | 6 | $196 |
| Insulet Corporation | 8 | $192 |
| Sequel Med Tech, LLC | 1 | $150 |
| Amgen Inc. | 5 | $107 |
| Corcept Therapeutics | 4 | $79 |
| Lilly USA, LLC | 2 | $55 |
| Dexcom, Inc. | 2 | $50 |
| BETA BIONICS, INC. | 4 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
Products named: FREESTYLE LIBRE 3, Omnipod, TWIIST, Ozempic, Korlym, TEPEZZA, JARDIANCE, Dexcom G6 Transmitter.
Industry payments across NY — which companies pay providers there.
